Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 131709, 11 pages
http://dx.doi.org/10.1155/2014/131709
Research Article

Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study

1Primary Health Care Center Raval, Gerència d’Àmbit d’Atenció Primària Barcelona Ciutat, Institut Catala de la Salut, Avenida Drassanes 17-21, 08001 Barcelona, Spain
2Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari de Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Avenida Gran Via de les Corts Catalanes, 587 Àtic, 08007 Barcelona, Spain
3Primary Health Care Center La Mina, Gerència d’Àmbit d’Atenció Primària Barcelona Ciutat, Institut Catala de la Salut, C/Mar s/n, Sant Adrià de Besòs, 08930 Barcelona, Spain
4Department of Endocrinology and Nutrition, Diabetes Unit, Hospital Clinic, University of Barcelona, C/Villarroel 170, 08036 Barcelona, Spain
5Department of Endocrinology & Nutrition, Health Sciences Research Institute and Hospital Universitari Germans Trias i Pujol, Carretera Canyet s/n, 08916 Badalona, Spain

Received 4 July 2014; Accepted 7 September 2014; Published 21 September 2014

Academic Editor: Alexandra Kautzky-Willer

Copyright © 2014 Josep Franch-Nadal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global estimates of the prevalence of diabetes for 2010 and 2030,” Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. R. Whiting, L. Guariguata, C. Weil, and J. Shaw, “IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030,” Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 311–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Guariguata, D. R. Whiting, I. Hambleton et al., “Global estimates of diabetes prevalence for 2013 and projections for 2035,” Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 137–149, 2014. View at Google Scholar
  4. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 6th edition, 2013.
  5. F. Soriguer, A. Goday, A. Bosch-Comas et al., “Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study,” Diabetologia, vol. 55, no. 1, pp. 88–93, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. P. Donahue and T. J. Orchard, “Diabetes mellitus and macrovascular complications: an epidemiological perspective,” Diabetes Care, vol. 15, no. 9, pp. 1141–1155, 1992. View at Publisher · View at Google Scholar · View at Scopus
  7. G. L. Booth, M. K. Kapral, K. Fung, and J. V. Tu, “Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study,” The Lancet, vol. 368, no. 9529, pp. 29–36, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Leal, A. M. Gray, and P. M. Clarke, “Development of life-expectancy tables for people with type 2 diabetes,” European Heart Journal, vol. 30, no. 7, pp. 834–839, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Gæde, P. Vedel, N. Larsen, G. V. H. Jensen, H.-H. Parving, and O. Pedersen, “Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes,” The New England Journal of Medicine, vol. 348, no. 5, pp. 383–393, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. R. R. Holman, S. K. Paul, M. A. Bethel, D. R. Matthews, and H. A. W. Neil, “10-Year follow-up of intensive glucose control in type 2 diabetes,” The New England Journal of Medicine, vol. 359, no. 15, pp. 1577–1589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Mannucci, I. Dicembrini, A. Lauria, and P. Pozzilli, “Is glucose control important for prevention of cardiovascular disease in diabetes?” Diabetes Care, vol. 36, supplement 2, pp. S259–S263, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. American Diabetes Association, “Standards of medical care in diabetes—2014,” Diabetes Care, vol. 37, supplement 1, pp. S14–S80, 2014. View at Publisher · View at Google Scholar
  13. C. B. Giorda, A. Avogaro, M. Maggini et al., “Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors,” Diabetes Care, vol. 31, no. 11, pp. 2154–2159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. C. H. Jørgensen, G. H. Gislason, O. Ahlehoff, C. Andersson, C. Torp-Pedersen, and P. R. Hansen, “Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus,” BMC Cardiovascular Disorders, vol. 14, article 4, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. T. J. Orchard, “The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus,” Annals of Medicine, vol. 28, no. 4, pp. 323–333, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. Kanaya, D. Grady, and E. Barrett-Connor, “Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis,” Archives of Internal Medicine, vol. 162, no. 15, pp. 1737–1745, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. W. L. Lee, A. M. Cheung, D. Cape, and B. Zinman, “Impact of diabetes on coronary artery disease in women and men: a meta- analysis of prospective studies,” Diabetes Care, vol. 23, no. 7, pp. 962–968, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. F. B. Hu, M. J. Stampfer, C. G. Solomon et al., “The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up,” Archives of Internal Medicine, vol. 161, no. 14, pp. 1717–1723, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Huxley, F. Barzi, and M. Woodward, “Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies,” British Medical Journal, vol. 332, no. 7533, pp. 73–78, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. W. P. Castelli, “Cardiovascular disease in women,” American Journal of Obstetrics and Gynecology, vol. 158, no. 6, part 2, pp. 1553–1560, 1988. View at Publisher · View at Google Scholar · View at Scopus
  21. A. P. V. Dantas, Z. B. Fortes, and M. H. C. de Carvalho, “Vascular disease in diabetic women: why do they miss the female protection?” Experimental Diabetes Research, vol. 2012, Article ID 570598, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. E. L. Barrett-Connor, B. A. Cohn, D. L. Wingard, and S. L. Edelstein, “Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study,” Journal of the American Medical Association, vol. 265, no. 5, pp. 627–631, 1991. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Juutilainen, S. Kortelainen, S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso, “Gender difference in the impact of type 2 diabetes on coronary heart disease risk,” Diabetes Care, vol. 27, no. 12, pp. 2898–2904, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Marrugat, J. Sala, and J. Aboal, “Epidemiology of cardiovascular disease in women,” Revista Espanola de Cardiologia, vol. 59, no. 3, pp. 264–274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Gouni-Berthold, H. K. Berthold, C. S. Mantzoros, M. Böhm, and W. Krone, “Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes,” Diabetes Care, vol. 31, no. 7, pp. 1389–1391, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. P. C. Gutiérrez, J. M. L. Bejarano, J. R. G. Juanatey, A. G. Núñez, F. J. P. Fernández, and A. N. Sardá, “Different approach in high-cardiovascular-risk women, compared to men: a multidisciplinary study-Spain,” Medicina Clinica, vol. 120, no. 12, pp. 451–455, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. S. D. Persell and D. W. Baker, “Aspirin use among adults with diabetes: recent trends and emerging sex disparities,” Archives of Internal Medicine, vol. 164, no. 22, pp. 2492–2499, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Tonstad, E. O. Rosvold, K. Furu, and S. Skurtveit, “Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001,” Journal of Internal Medicine, vol. 255, no. 4, pp. 494–502, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. D. J. Wexler, R. W. Grant, J. B. Meigs, D. M. Nathan, and E. Cagliero, “Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes,” Diabetes Care, vol. 28, no. 3, pp. 514–520, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Vidal-Pérez, F. Otero-Raviña, L. Grigorian-Shamagian et al., “Sex does not influence prognosis in diabetic patients. The Barbanza Diabetes study,” Revista Espanola de Cardiologia, vol. 63, no. 2, pp. 170–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Franzini, D. Ardigò, F. Cavalot et al., “Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 23, no. 3, pp. 235–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Penno, A. Solini, E. Bonora et al., “Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study,” Journal of Internal Medicine, vol. 274, no. 2, pp. 176–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. E. W. Gregg, Q. Gu, Y. J. Cheng, K. M. V. Narayan, and C. C. Cowie, “Mortality trends in men and women with diabetes, 1971 to 2000,” Annals of Internal Medicine, vol. 147, no. 3, pp. 149–155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. A. D. Morris, D. I. R. Boyle, R. MacAlpine et al., “The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register,” British Medical Journal, vol. 315, no. 7107, pp. 524–528, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Eliasson, J. Cederholm, P. Nilsson, and S. Gudbjörnsdóttir, “The gap between guidelines and reality: type 2 diabetes in a national diabetes register 1996–2003,” Diabetic Medicine, vol. 22, no. 10, pp. 1420–1426, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Vinagre, M. Mata-Cases, E. Hermosilla et al., “Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain),” Diabetes Care, vol. 35, no. 4, pp. 774–779, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. J. A. M. Sperl-Hillen and P. J. O'Connor, “Factors driving diabetes care improvement in a large medical group: ten years of progress,” American Journal of Managed Care, vol. 11, supplement 5, pp. S177–S185, 2005. View at Google Scholar · View at Scopus
  38. B. Bolíbar, F. Fina Avilés, R. Morros et al., “SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research,” Medicina Clinica, vol. 138, no. 14, pp. 617–621, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Mata-Cases, P. Roura-Olmeda, M. Berengué-Iglesias et al., “Fifteen years of continuous improvement of quality care of type 2 diabetes mellitus in primary care in Catalonia, Spain,” International Journal of Clinical Practice, vol. 66, no. 3, pp. 289–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Mata-Cases, F. X. Cos-Claramunt, R. Morros et al., Abordatge de la Diabetis Mellitus Tipus 2, Guies de Pràctica Clínica, num 15, Institut Català de la Salut, Barcelona, Spain, 2010.
  41. Ministerio de Sanidad y Consumo, “Guía de práctica clínica sobre diabetes tipo 2,” 2008, http://www.guiasalud.es/viewGPC.asp?idGuia=429.
  42. E. Raum, H. U. Krämer, G. Rüter et al., “Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 97, no. 3, pp. 377–384, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. J. L. Strom Williams, C. P. Lynch, R. Winchester et al., “Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes,” Diabetes Technology and Therapeutics, vol. 16, no. 7, pp. 421–427, 2014. View at Publisher · View at Google Scholar
  44. H. U. Krämer, E. Raum, G. Rüter et al., “Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study,” Cardiovascular Diabetology, vol. 11, article 88, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Ferrara, C. M. Mangione, C. Kim et al., “Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) study,” Diabetes Care, vol. 31, no. 1, pp. 69–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Becker, G. Bos, F. de Vegt et al., “Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease: 10-Year follow-up of the Hoorn study,” European Heart Journal, vol. 24, no. 15, pp. 1406–1413, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Baviera, P. Santalucia, L. Cortesi et al., “Sex differences in cardiovascular outcomes, pharmacological treatments and indicators of care in patients with newly diagnosed diabetes: analyses on administrative database,” European Journal of Internal Medicine, vol. 25, no. 3, pp. 270–275, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Mo, L. M. Pogany, F. C. K. Li, and H. Morrison, “Prevalence of diabetes and cardiovascular comorbidity in the Canadian Community Health Survey 2002–2003,” TheScientificWorldJournal, vol. 6, pp. 96–105, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Comaschi, C. Coscelli, D. Cucinotta, P. Malini, E. Manzato, and A. Nicolucci, “Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 15, no. 3, pp. 204–211, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. G. J. Winston, R. G. Barr, O. Carrasquillo, A. G. Bertoni, and S. Shea, “Sex and racial/ethnic differences in cardiovascular disease risk factor treatment and control among individuals with diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA),” Diabetes Care, vol. 32, no. 8, pp. 1467–1469, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Sandín, A. Espelt, A. Escolar-Pujolar, L. Arriola, and I. Larrañaga, “Desigualdades de género y diabetes mellitus tipo 2: la importancia de la diferencia,” Avances en Diabetología, vol. 27, no. 3, pp. 78–87, 2011. View at Google Scholar
  52. M. Sekerija, T. Poljicanin, K. Erjavec, A.-M. Liberati-Cizmek, M. Prašek, and Z. Metelko, “Gender differences in the control of cardiovascular risk factors in patients with type 2 diabetes -a cross-sectional study,” Internal Medicine, vol. 51, no. 2, pp. 161–166, 2012. View at Publisher · View at Google Scholar
  53. C. J. Homko, L. Zamora, W. P. Santamore, A. Kashem, T. McConnell, and A. A. Bove, “Gender differences in cardiovascular risk factors and risk perception among individuals with diabetes,” Diabetes Educator, vol. 36, no. 3, pp. 483–488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Correa-de-Araujo, K. McDermott, and E. Moy, “Gender differences across racial and ethnic groups in the quality of care for diabetes,” Women's Health Issues, vol. 16, no. 2, pp. 56–65, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Ferrara, D. F. Williamson, A. J. Karter, T. J. Thompson, and C. Kim, “Sex differences in qualify of health care related to ischemic heart disease prevention in patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) study, 2000-2001,” Diabetes Care, vol. 27, no. 12, pp. 2974–2976, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. D. P. Nau and U. Mallya, “Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization,” The American Journal of Managed Care, vol. 11, no. 2, pp. 69–73, 2005. View at Google Scholar · View at Scopus
  57. J. M. Walsh and M. Pignone, “Drug Treatment of Hyperlipidemia in Women,” Journal of the American Medical Association, vol. 291, no. 18, pp. 2243–2252, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Mora, R. J. Glynn, J. Hsia, J. G. MacFadyen, J. Genest, and P. M. Ridker, “Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials,” Circulation, vol. 121, no. 9, pp. 1069–1077, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Seshadri, A. Beiser, M. Kelly-Hayes et al., “The lifetime risk of stroke: estimates from the framingham study,” Stroke, vol. 37, no. 2, pp. 345–350, 2006. View at Publisher · View at Google Scholar · View at Scopus